Ticker Scorecard - CRMD Basics Company: CorMedix Inc. IPO Date: May 13, 2010 Sector: Healthcare Industry: Biotech Market Cap: $505.44M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 4.18% Avg Daily Range (30 D): $0.27 | 2.80% Avg Daily Range (90 D): $0.28 | 2.79% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): 1M Avg Daily Volume (90 D): 1.04M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 98 Institutional Trades Total Inst.Trades: 150 Avg Inst. Trade: $1.64M Avg Inst. Trade (30 D): $1.82M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .21M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $1.5M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 251.94K     News Dec 10, 2024 @ 7:45 AM Closed System Transfer Device Market Size Poised t... Source: Polaris Market Research Sep 9, 2024 @ 8:06 PM Here's Why CorMedix Is a Great 'Buy the Bottom' St... Source: Zacks Sep 9, 2024 @ 2:52 PM CorMedix Inc. Announces New Commercial Agreement Source: N/A Jun 6, 2024 @ 12:30 PM CorMedix Inc. Announces CMS Grants Pass-Through St... Source: CorMedix, Inc. May 9, 2024 @ 3:00 PM CorMedix (CRMD) Q1 2024 Earnings Call Transcript Source: newsfeedback@fool.com (Motley Fool Transcribing) Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.8 $-.05 $-.25 Diluted EPS $-.8 $-.05 $-.25 Revenue $ 11.44M $ 11.46M $ .81M Gross Profit $ $ 10.77M $ .3M Net Income / Loss $ -46.15M $ -2.78M $ -14.15M Operating Income / Loss $ -50.96M $ -3.29M $ -15.3M Cost of Revenue $ $ .69M $ .51M Net Cash Flow $ -18.11M $ 6.75M $ -6.71M PE Ratio     Splits Mar 26, 2019:   5:1